Sort   by:  
 Page size 
UnknownSusceptibility to chronic social stress increases plaque progression, vulnerability and platelet activation.
Not available
S-EPMC5490439 | biostudies-literature
UnknownReal-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
Not available
S-EPMC10491680 | biostudies-literature
UnknownUsing peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
Not available
S-EPMC10583024 | biostudies-literature
UnknownSymptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Not available
S-EPMC7649863 | biostudies-literature
Sort   by:  
 Page size